A new law allows physicians and patients to collaborate to secure experimental drugs.
Colorado recently became the first state to pass a law giving terminally ill patients the right to use experimental drugs.
The new law allows physicians and patients to collaborate to secure experimental drugs with the permission of pharmaceutical manufacturers.
Supporters of the bill have argued that the law would help patients avoid the long FDA drug approval process, but opponents point out that such laws circumvent the federal process of drug development, which is meant to ensure the safety of drugs.
Continue Reading
Renal & Urology News would like to know what urologists and nephrologists think about this, so please answer following poll question. All responses are anonymous.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.